Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 21-Feb-23 8:05 PM View:  | Lehr Martin A. Chief Executive Officer Director | Context Therapeutics Inc. (CNTX) | 21-Feb-23 | Private Purchase (Planned) | 5,823 | $0.84 | $4,900.05 | < 1% 974.07K to 979.89K | |
| 13-Feb-23 4:03 PM View: | Lehr Martin A. Chief Executive Officer Director | Context Therapeutics Inc. (CNTX) | 13-Feb-23 | Private Purchase (Planned) | 5,606 | $0.87 | $4,900.77 | < 1% 968.46K to 974.07K | |
| 06-Feb-23 4:03 PM View: | Lehr Martin A. Chief Executive Officer Director | Context Therapeutics Inc. (CNTX) | 06-Feb-23 | Private Purchase (Planned) | 5,040 | $0.97 | $4,900.39 | < 1% 963.42K to 968.46K | |
| 30-Jan-23 4:03 PM View: | Lehr Martin A. Chief Executive Officer Director | Context Therapeutics Inc. (CNTX) | 30-Jan-23 | Private Purchase (Planned) | 7,027 | $0.70 | $4,900.63 | < 1% 956.39K to 963.42K | |
| 23-Jan-23 5:03 PM View: | Lehr Martin A. Chief Executive Officer Director | Context Therapeutics Inc. (CNTX) | 23-Jan-23 | Private Purchase (Planned) | 6,839 | $0.72 | $4,900.83 | < 1% 949.56K to 956.39K | |
| 18-Jan-23 4:04 PM View: | Lehr Martin A. Chief Executive Officer Director | Context Therapeutics Inc. (CNTX) | 17-Jan-23 | Private Purchase (Planned) | 6,783 | $0.74 | $4,995.00 | < 1% 942.77K to 949.56K | |
| 19-Dec-22 4:11 PM View: | Lehr Martin A. Chief Executive Officer Director | Context Therapeutics Inc. (CNTX) | 16-Dec-22 | Private Purchase | 20,000 | $0.74 | $14,796.00 | 2% 922.77K to 942.77K | |
| 19-Dec-22 4:22 PM View: | Minai-Azary Jennifer Lynn Chief Financial Officer | Context Therapeutics Inc. (CNTX) | 16-Dec-22 | Private Purchase | 25,000 | $0.74 | $18,500.00 | 167% 15.0K to 40.0K | |
| 12-Dec-22 4:15 PM View: | Levit Alex C. Chief Legal Officer, Corp. Sec | Context Therapeutics Inc. (CNTX) | 09-Dec-22 | Private Purchase | 6,000 | $0.85 | $5,094.60 | 11% 55.98K to 61.98K | |
| 22-Aug-22 4:04 PM View: | Lehr Martin A. Chief Executive Officer Director | Context Therapeutics Inc. (CNTX) | 19-Aug-22 | Private Purchase | 13,000 | $1.85 | $24,064.30 | 1% 909.77K to 922.77K | |
| 17-Aug-22 5:23 PM View: | Minai-Azary Jennifer Lynn Chief Financial Officer | Context Therapeutics Inc. (CNTX) | 17-Aug-22 | Private Purchase | 15,000 | $1.80 | $27,000.00 | 100% 0 to 15.0K | |
| 17-Aug-22 5:22 PM View: | Sahmoud Tarek Chief Medical Officer | Context Therapeutics Inc. (CNTX) | 16-Aug-22 | Private Purchase | 10,000 | $1.95 | $19,500.00 | 100% 0 to 10.0K | |
| 20-Dec-21 4:02 PM View: | Lehr Martin A. Chief Executive Officer Director | Context Therapeutics Inc. (CNTX) | 16-Dec-21 | Market Purchase | 13,000 | $3.22 | $41,849.60 | 1% 896.77K to 909.77K | (8%) |
| 25-Oct-21 5:30 PM View: | Lehr Martin A. Chief Executive Officer Director | Context Therapeutics Inc. (CNTX) | 22-Oct-21 | Conversion | 797,198 | -- | -- | 890% 89.58K to 886.78K | |
| 25-Oct-21 5:30 PM View: | Levit Alex C. Chief Legal Officer, Corp. Sec | Context Therapeutics Inc. (CNTX) | 22-Oct-21 | Private Purchase | 3,000 | $5.00 | $15,000.00 | 100% 0 to 3.0K | |
| 25-Oct-21 5:30 PM View: | Lehr Martin A. Chief Executive Officer Director | Context Therapeutics Inc. (CNTX) | 22-Oct-21 | Exercise (out-of-the-money) | 52,680 | $7.14 | $376,135.00 | 6% 886.78K to 939.46K | |
| 25-Oct-21 5:29 PM View: | Dick Evan G. SVP of R&D | Context Therapeutics Inc. (CNTX) | 22-Oct-21 | Conversion | 26,587 | -- | -- | 44% 60.55K to 87.14K | |
| 25-Oct-21 5:30 PM View: | Lehr Martin A. Chief Executive Officer Director | Context Therapeutics Inc. (CNTX) | 22-Oct-21 | Private Purchase | 10,000 | $5.00 | $50,000.00 | 1% 939.46K to 949.46K |
